Publications

HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease

Wieland A, Etzion O, Ali RO, Levy E, Kleiner D, Helmke SM, Heller T, Everson GT | Clin Gastroenterol Hepatol. 2021 Apr 22;S1542-3565(21)00464-X

Predicting clinical decompensation in patients with cirrhosis using the HepQuant SHUNT Test

Fallahzadeh MA, Hansen DJ, Trotter JF, Everson GT, Saracino G, Rahimi RS, Helmke S, Boutte J, Asrani SK | Aliment Pharmacol Ther. 2021 Apr;53(8):928-938

Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test

Maan R, Sonneveld MJ | Aliment Pharmacol Ther. 2021 Apr;53(8):939-940

Authors’ Response to “Editorial: stratifying risk of adverse outcomes in cirrhosis: the Hepquant SHUNT test”

Asrani S, Everson GT | Aliment Pharmacol Ther. 2021 Apr;53(8):941-942

How clinicians may use tests of hepatic function now and in the future

Ghaziani TT, Kwo PY | Transl Res. 2021; 233:1-4

Deterioration in liver function after liver-directed therapy for hepatocellular carcinoma measured by cholate clearance

Maarouf A. Hoteit, Andrezj Wojcieszynski, Brian Currie, Matthew H. Levine, Kimberly A. Forde, Kim A. Reiss, Greg Nadolski, Michael C. Soulen3, Steve Helmke, Gregory T. Everson, Edgar Ben-Josef | GastroHep. 2020;00:1–8

Assessing hepatic impairment in Fontan‐associated liver disease using the HepQuant SHUNT test

Lemmer A, VanWagner L, Gasanova Z, Helmke S, Everson GT, Ganger D | Congenit Heart Dis. 2019; 14:978-986

Noninvasive assessment of liver function

Helmke S, Colmenero J, Everson GT | Curr Opin Gastroenterol. 2015 May;31(3):199-208

Functional Elements Associated With Hepatic Regeneration in Living Donors After Right Hepatic Lobectomy

Gregory T. Everson, John C. Hoefs, Claus U. Niemann, Kim M. Olthoff, Robert Dupuis, Shannon Lauriski, Andrea Herman, Norah Milne, Brenda W. Gillespie, Nathan P. Goodrich, and James E. Everhart | Liver Transpl 2013; 19:292–304

Quantitative Liver Function Tests Improve the Prediction of Clinical Outcomes in Chronic Hepatitis C: Results From the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial

Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, Timothy R. Morgan, Richard K. Sterling, David A. Wagner, Shannon Lauriski, Teresa M. Curto, Anne Stoddard, and Elizabeth C. Wright, the HALT-C Trial Group | Hepatology 2012; 55:1019-1029